TrumpRx now prioritizes generics that comprise ~90% of US prescriptions, shifting from a brand-heavy list toward medications more likely to affect broad population-level out-of-pocket spending.

FDA approval brings Enhertu into early breast cancer treatment, boosting response before surgery and cutting recurrence risk ...

Efficacy and Safety of Sotatercept in Patients With Pulmonary Arterial Hypertension (PAH) Associated With Connective Tissue ...

Manhattan cordon pricing south of 60th Street reduced traffic volumes and increased bus use, with hypothesized local/regional ...

PASSAGE study data showed tezepelumab improved asthma outcomes across diverse, underrepresented patient populations. Data presented at the American Thoracic Society 2026 International Conference in ...

Inverse-probability reweighting of NHANES 1988–1991 to 2021–2023 demographics projected 5.3 million US adults with ASCVD and ...

Global stroke incidence and prevalence continue rising alongside high, underrecognized OSA prevalence and rapidly expanding diabetes burden, with substantial bidirectional comorbidity in type 2 ...

Communication gaps persisted despite shared decision-making norms, with limited patient-perceived comprehension and ...

This study evaluated differences in racial and ethnic disparities in surgical outcomes between Medicare Advantage and traditional Medicare beneficiaries, finding consistent but nonuniform smaller ...

Preterm birth is a lifelong cardiopulmonary risk marker, with markedly higher cardiovascular disease and heart failure risk ...

Medication adherence is a key to improving outcomes, reducing costs, and strengthens the patient experience, making it an ...

Drug overdoses have declined for a third straight year, according to preliminary data released by the CDC on May 13. 1 The ...